Dianthus Therapeutics Banner

Email Alerts

DIANTHUS THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE PHASE 1 DATA AND DEBUTS TRADING ON NASDAQ AS DNTH

To opt-in for investor email alerts, please select at least one alert option and enter your email address in the field below. After submitting your request, an activation email will be sent to the address provided. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. If you would like to opt out of email alerts, you can unsubscribe here